Stuart F A, Segal T Y, Keady S
Child and Family Department, Tavistock Centre, 120 Belsize Lane, London NW3 5BA, UK.
Arch Dis Child. 2005 May;90(5):500-6. doi: 10.1136/adc.2003.041541.
Children and adolescents treated with oral, inhaled, and intravenous corticosteroids (CS) may experience adverse psychological side effects (APSE), including psychotic symptoms. These can occur at any point during treatment, including withdrawal. In this paper the literature on these effects in children and adults is reviewed. From the evidence available, it is not possible to give reliable estimates for incidence or prevalence of APSE, nor clear risk factors. Some evidence is reported to suggest that oral dexamethasone treatment may carry a higher risk of APSE than other CS, but this requires further investigation. There is evidence from the adult literature that higher CS doses increase the risk of APSE. However, the dose response effect is not straightforward or predictable for individuals or groups. This is likely to be a reflection of the complex effects of CS on the central nervous system and the probable interplay between individual susceptibility, disease factors, and external environmental stressors in the emergence of APSE. More research is required to further our understanding of the adverse effects of these clinically valuable agents.
接受口服、吸入和静脉注射皮质类固醇(CS)治疗的儿童和青少年可能会出现不良心理副作用(APSE),包括精神症状。这些症状可在治疗期间的任何时候出现,包括停药期。本文回顾了有关儿童和成人这些影响的文献。根据现有证据,无法给出APSE发病率或患病率的可靠估计,也无法明确风险因素。有报道称,一些证据表明口服地塞米松治疗可能比其他CS带来更高的APSE风险,但这需要进一步研究。来自成人文献的证据表明,较高的CS剂量会增加APSE风险。然而,剂量反应效应对于个体或群体来说并不直接或可预测。这可能反映了CS对中枢神经系统的复杂影响以及个体易感性、疾病因素和外部环境应激源在APSE出现过程中可能的相互作用。需要更多研究来进一步了解这些具有临床价值的药物的不良反应。